U.S. Pharma Stock News

In the past quarter, NOV Inc. repurchased 3,500,000 shares for US$67 million, completing a broader buyback of 40,475,436 shares for US$611.23 million under its April 26, 2024 authorization, while reporting first-quarter 2026 revenue of US$2,052 million and net income of US$19 million, both lower than a year earlier. The earnings release, guidance for a 4% to 6% year-over-year revenue decline in the second quarter of 2026, and Barclays’ downgrade to Underweight despite a more positive view on...

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...

In early May 2026, TowneBank was caught up in a broader regional bank pullback as renewed U.S.-Iran tensions drove oil prices higher and pushed Treasury yields toward nine-month highs, rekindling stagflation worries. This episode highlights how quickly the macro backdrop, especially inflation-driven moves in the yield curve, can alter perceptions of earnings resilience for regional lenders like TowneBank. We’ll now examine how this inflation-driven shift in Treasury yields may influence...

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...

Wondering if Intellia Therapeutics at around US$13.71 is offering value or just volatility? This article walks through what the current price may be implying about the stock. The stock has returned 1.7% over the last 7 days, 1.2% over 30 days, 48.9% year to date and 65.6% over the past year, while longer term 3 year and 5 year returns of 69.3% and 77.5% declines show how sentiment around the stock has shifted over time. Recent headlines around Intellia Therapeutics have focused on its...

In early May 2026, AdaptHealth Corp. reported first-quarter net revenue of US$819.8 million, a wider net loss of US$16.04 million, completed a US$1.10 billion refinancing of its senior secured credit facility, and raised its 2026 net revenue guidance to US$3.45 billion–US$3.52 billion. Management highlighted that the stronger balance sheet will support disciplined tuck-in acquisitions in core Sleep and Respiratory Health, alongside a large de novo expansion and an advanced digital patient...

KeyCorp (KEY) stock is in focus after KeyBank moved to expand its Middle Market commercial banking capabilities in Southeast Michigan, targeting companies with revenues between $10 million and $1 billion across the region. See our latest analysis for KeyCorp. At a share price of US$21.69, KEY has seen a 5.19% 1 month share price return, while its 1 year total shareholder return of 45.68% and 3 year total shareholder return of about 2.8x suggest stronger momentum over longer periods despite a...

Q1 2026 results reset the earnings picture for Chime Financial (CHYM) Chime Financial (CHYM) opened 2026 with Q1 revenue of US$647.4 million and basic EPS of US$0.14, alongside net income of US$53.5 million. The trailing twelve months still show a net loss of US$956.5 million and basic EPS of US$3.03 loss. Over recent quarters, the company has seen revenue move from US$475.2 million in Q4 2024 to US$518.7 million in Q1 2025, US$528.1 million in Q2 2025, US$543.5 million in Q3 2025, US$596.4...

UDR (NYSE:UDR) has shifted to monthly dividend payments, becoming the first major apartment REIT to use this payout schedule. The company paired the change in dividend frequency with an expansion of its share repurchase program. These moves followed Q1 results that were described as better than expected. UDR focuses on owning and operating multifamily apartment communities, a segment that often attracts income focused investors looking for regular cash flow from real estate. The switch to...

What Korn Ferry’s Recent Performance Data Suggests for Investors Korn Ferry (KFY) stock has moved quietly higher over the past month, with recent returns and fundamentals giving investors fresh data points on this US$3.4b organizational consulting company and its diversified revenue base. See our latest analysis for Korn Ferry. At a share price of US$67.14, Korn Ferry’s 6.05% 1 month share price return contrasts with a slightly negative 90 day move, while the 51.17% 3 year total shareholder...

Universal Display (NasdaqGS:OLED) and SFC Co. Ltd. agreed to co-develop and commercialize highly efficient phosphorescent OLED material systems. The partnership focuses on materials for next generation display and lighting applications, targeting energy efficiency and performance improvements. The collaboration is positioned as part of Universal Display's broader effort to expand its OLED materials ecosystem. Universal Display, best known for its OLED materials and IP portfolio, sits at the...

It's shaping up to be a tough period for The Hackett Group, Inc. ( NASDAQ:HCKT ), which a week ago released some...

Delek Logistics Partners (NYSE:DKL) has launched US$800 million in new senior notes due 2034. The partnership has also started a cash tender offer for its existing 2028 senior notes. The refinancing is intended to adjust its debt profile by using proceeds from the 2034 notes to address higher coupon 2028 and 2029 notes. For you as an investor, this refinancing move goes straight to the core of how Delek Logistics Partners, a midstream operator, finances its business. Adjusting maturities...

How the Star Wars collaboration frames Bath & Body Works stock today Bath & Body Works (BBWI) has teamed up with Disney on a limited edition Star Wars: The Mandalorian and Grogu collection, tying product launches to the May film release and May the 4th promotions. For investors, this type of licensing and cross marketing push can be a useful lens for thinking about brand reach, customer engagement and how much value the market currently assigns to the company’s franchise driven product...

UWM Holdings Corporation recently reported first-quarter 2026 results, swinging to a net income of US$25.3 million from a net loss of US$13.68 million a year earlier, and affirmed a quarterly dividend of US$0.10 per share payable on July 9, 2026. Management linked the return to profitability to higher mortgage origination volumes and outlined a move to bring all loan servicing in-house by year-end to improve efficiency and client experience. We’ll now explore how UWM’s return to...

Hercules Capital, Inc. has already reported first-quarter 2026 results, with total investment income rising to US$141.54 million while net income slipped to US$42.5 million, alongside announcing executive promotions and a combined regular and special cash dividend of US$0.47 per share. At the same time, the company is facing multiple securities class action lawsuits alleging overstated due diligence and portfolio valuations, putting its underwriting and reporting practices under legal and...

Kulicke and Soffa Industries (KLIC) has just turned in a punchy Q2 2026 scorecard, with revenue of US$242.6 million and basic EPS of US$0.67, alongside trailing 12 month EPS of US$1.05 on revenue of US$768.2 million. Over the past few quarters the company has seen revenue move from US$161.9 million in Q2 2025 to US$148.4 million in Q3 2025, US$177.6 million in Q4 2025, US$199.6 million in Q1 2026 and now US$242.6 million in Q2 2026. Quarterly EPS ranged from a loss of US$1.59 in Q2 2025 to...

Marsh, a business of Marsh & McLennan Companies, has entered a multi year global partnership with Formula 1. Marsh becomes Formula 1's first Official Risk Partner and Insurance Brokering Partner under this agreement. The partnership positions Marsh & McLennan (NYSE:MRSH) alongside one of the most widely followed global sports properties. For investors watching Marsh & McLennan at a current share price of $166.03, this Formula 1 tie up comes after a mixed share performance picture. The stock...

What Tri Pointe Homes’ Recent Returns Tell You Tri Pointe Homes (TPH) has drawn attention after a past 3 months total return of 32.4% and year to date return of 48.7%. These figures are prompting investors to reassess the stock’s recent momentum and underlying fundamentals. See our latest analysis for Tri Pointe Homes. Tri Pointe Homes’ recent share price return over 90 days of 32.4% and year to date share price return of 48.7%, alongside a 5 year total shareholder return of 93.37%, points to...

If you are wondering whether J. M. Smucker at around US$99 a share looks cheap, expensive, or somewhere in between, the starting point is understanding how its current price lines up against different measures of value. The stock is trading near US$99.44, with recent returns of 1.4% over 7 days, 5.6% over 30 days and 2.9% year to date. Over the last year the return sits at a 7.7% decline, and the 3 and 5 year returns are 29.9% and 14.3% declines respectively. These figures can affect how...

CME Group (NasdaqGS:CME) introduced the U.S. dollar RepoFunds Rate (RFR USD) this week as a new overnight repo market benchmark. The company also listed Avalanche (AVAX) and Sui (SUI) cryptocurrency futures, expanding its regulated crypto derivatives suite. These launches extend CME Group's reach in both fixed income market infrastructure and institutional crypto trading. CME Group, known for its global derivatives exchanges, is leaning further into rate benchmarks and digital assets as...

Toll Brothers has recently expanded its luxury footprint with multiple US community launches and model-home openings, including Irvine’s Great Park Neighborhoods, La Quinta’s Griffin Ranch, and new projects in Texas, Florida, and Connecticut, offering homes from the upper US$300,000s to over US$2.27 million. These developments highlight Toll Brothers’ focus on high-end, amenity-rich communities across diverse regions, even as sector commentary points to softer builder confidence, weaker...

Incyte (INCY) stock is in focus after the US FDA approved once daily Jakafi XR, along with positive Phase 3 Opzelura data in atopic dermatitis and orphan drug designation for a pancreatic cancer therapy. See our latest analysis for Incyte. Despite a 1-day share price decline of 2.08% to about $97.77, Incyte’s 63.69% 1-year total shareholder return and recent FDA wins suggest momentum has been building around its pipeline and diversification efforts. If recent oncology and dermatology updates...